Patch delivers drug, gene, and light-based therapy to tumor sites
From an article by Helen Knight at Phys.org: Approximately one in 20 people will develop colorectal cancer in their lifetime, making it the third-most prevalent form of the disease in the U.S. In Europe, it is the second-most common form of cancer. The most widely used first line of treatment is surgery, but this can result [...]









